Defective synaptic transmission causes disease signs in a mouse model of Juvenile Neuronal Ceroid Lipofuscinosis

  1. Benedikt Grünewald
  2. Maren D Lange
  3. Christian Werner
  4. Aet O'Leary
  5. Andreas Weishaupt
  6. Sandy Popp
  7. David A Pearce
  8. Heinz Wiendl
  9. Andreas Reif
  10. Hans C Pape
  11. Klaus V Toyka
  12. Claudia Sommer
  13. Christian Geis  Is a corresponding author
  1. Jena University Hospital, Germany
  2. University of Münster, Germany
  3. University Hospital Frankfurt, Germany
  4. University Hospital Würzburg, Germany
  5. Sanford Research, United States

Abstract

Juvenile neuronal ceroid lipofuscinosis (JNCL or Batten disease) caused by mutations in the CLN3 gene is the most prevalent inherited neurodegenerative disease in childhood resulting in widespread central nervous system dysfunction and premature death. The consequences of CLN3 mutation on the progression of the disease, on neuronal transmission, and on central nervous network dysfunction are poorly understood. We used Cln3 knockout (Cln3Δex7/8) mice and found increased anxiety-related behavior and impaired aversive learning as well as markedly affected motor function including disordered coordination. Patch-clamp and loose-patch recordings revealed severely affected inhibitory and excitatory synaptic transmission in amygdala, hippocampus, and in cerebellar networks. Changes in presynaptic release properties may result from dysfunction of CLN3 protein. Furthermore, loss of calbindin, neuropeptide Y, parvalbumin, and GAD65-positive interneurons in central networks collectively support the hypothesis that degeneration of GABAergic interneurons may be the cause of supraspinal GABAergic disinhibition.

Article and author information

Author details

  1. Benedikt Grünewald

    Hans-Berger Department of Neurology, Jena University Hospital, Jena, Germany
    Competing interests
    The authors declare that no competing interests exist.
  2. Maren D Lange

    Institute of Physiology I, University of Münster, Münster, Germany
    Competing interests
    The authors declare that no competing interests exist.
  3. Christian Werner

    Hans-Berger Department of Neurology, Jena University Hospital, Jena, Germany
    Competing interests
    The authors declare that no competing interests exist.
  4. Aet O'Leary

    Department of Psychiatry, Psychosomatic Medicine and Psychotherapy, University Hospital Frankfurt, Frankfurt, Germany
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-6783-4729
  5. Andreas Weishaupt

    Department of Neurology, University Hospital Würzburg, Würzburg, Germany
    Competing interests
    The authors declare that no competing interests exist.
  6. Sandy Popp

    Department of Psychiatry, Psychosomatics and Psychotherapy, University Hospital Würzburg, Würzburg, Germany
    Competing interests
    The authors declare that no competing interests exist.
  7. David A Pearce

    Sanford Children´s Health Research Center, Sanford Research, Sioux Falls, United States
    Competing interests
    The authors declare that no competing interests exist.
  8. Heinz Wiendl

    Department of Neurology, University of Münster, Münster, Germany
    Competing interests
    The authors declare that no competing interests exist.
  9. Andreas Reif

    Department of Psychiatry, Psychosomatic Medicine and Psychotherapy, University Hospital Frankfurt, Frankfurt, Germany
    Competing interests
    The authors declare that no competing interests exist.
  10. Hans C Pape

    Institute of Physiology I, University of Münster, Münster, Germany
    Competing interests
    The authors declare that no competing interests exist.
  11. Klaus V Toyka

    Department of Neurology, University Hospital Würzburg, Würzburg, Germany
    Competing interests
    The authors declare that no competing interests exist.
  12. Claudia Sommer

    Department of Neurology, University Hospital Würzburg, Würzburg, Germany
    Competing interests
    The authors declare that no competing interests exist.
  13. Christian Geis

    Hans-Berger Department of Neurology, Jena University Hospital, Jena, Germany
    For correspondence
    christian.geis@med.uni-jena.de
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-9859-581X

Funding

Deutsche Forschungsgemeinschaft (SFB 581 [TP A7])

  • Klaus V Toyka
  • Claudia Sommer

Deutsche Forschungsgemeinschaft (SFB/TR 166 [B2])

  • Christian Geis

Deutsche Forschungsgemeinschaft (SFB/TR 58)

  • Maren D Lange
  • Hans C Pape

German Federal Ministry of Education and Research (Center for Sepsis Control and Care)

  • Christian Geis

IZKF University Hospital Jena

  • Benedikt Grünewald
  • Christian Geis

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Animal experimentation: All animal experiments were approved by the respective Bavarian and Thuringian state authorities (No. 55.5-2531.01-12/10; 78/05 and 02-44/12). All efforts were made to minimize animal suffering and to reduce the number of animals used. The study was performed in accordance with the ARRIVE guidelines for reporting animal research (Kilkenny et al., 2010).

Copyright

© 2017, Grünewald et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 1,979
    views
  • 303
    downloads
  • 28
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Benedikt Grünewald
  2. Maren D Lange
  3. Christian Werner
  4. Aet O'Leary
  5. Andreas Weishaupt
  6. Sandy Popp
  7. David A Pearce
  8. Heinz Wiendl
  9. Andreas Reif
  10. Hans C Pape
  11. Klaus V Toyka
  12. Claudia Sommer
  13. Christian Geis
(2017)
Defective synaptic transmission causes disease signs in a mouse model of Juvenile Neuronal Ceroid Lipofuscinosis
eLife 6:e28685.
https://doi.org/10.7554/eLife.28685

Share this article

https://doi.org/10.7554/eLife.28685

Further reading

    1. Neuroscience
    Selene Seoyun Lee, Livia Civitelli, Laura Parkkinen
    Research Article

    The alpha-synuclein (αSyn) seeding amplification assay (SAA) that allows the generation of disease-specific in vitro seeded fibrils (SAA fibrils) is used as a research tool to study the connection between the structure of αSyn fibrils, cellular seeding/spreading, and the clinicopathological manifestations of different synucleinopathies. However, structural differences between human brain-derived and SAA αSyn fibrils have been recently highlighted. Here, we characterize the biophysical properties of the human brain-derived αSyn fibrils from the brains of patients with Parkinson’s disease with and without dementia (PD, PDD), dementia with Lewy bodies (DLB), multiple system atrophy (MSA), and compare them to the ‘model’ SAA fibrils. We report that the brain-derived αSyn fibrils show distinct biochemical profiles, which were not replicated in the corresponding SAA fibrils. Furthermore, the brain-derived αSyn fibrils from all synucleinopathies displayed a mixture of ‘straight’ and ‘twisted’ microscopic structures. However, the PD, PDD, and DLB SAA fibrils had a ’straight’ structure, whereas MSA SAA fibrils showed a ‘twisted’ structure. Finally, the brain-derived αSyn fibrils from all four synucleinopathies were phosphorylated (S129). Interestingly, phosphorylated αSyn were carried over to the PDD and DLB SAA fibrils. Our findings demonstrate the limitation of the SAA fibrils modeling the brain-derived αSyn fibrils and pay attention to the necessity of deepening the understanding of the SAA fibrillation methodology.

    1. Neuroscience
    Mazen Makke, Alejandro Pastor-Ruiz ... Dieter Bruns
    Research Article

    Complexin determines magnitude and kinetics of synchronized secretion, but the underlying molecular mechanisms remained unclear. Here, we show that the hydrophobic face of the amphipathic helix at the C-terminus of Complexin II (CpxII, amino acids 115–134) binds to fusion-promoting SNARE proteins, prevents premature secretion, and allows vesicles to accumulate in a release-ready state in mouse chromaffin cells. Specifically, we demonstrate that an unrelated amphipathic helix functionally substitutes for the C-terminal domain (CTD) of CpxII and that amino acid substitutions on the hydrophobic side compromise the arrest of the pre-fusion intermediate. To facilitate synchronous vesicle fusion, the N-terminal domain (NTD) of CpxII (amino acids 1–27) specifically cooperates with synaptotagmin I (SytI), but not with synaptotagmin VII. Expression of CpxII rescues the slow release kinetics of the Ca2+-binding mutant Syt I R233Q, whereas the N-terminally truncated variant of CpxII further delays it. These results indicate that the CpxII NTD regulates mechanisms which are governed by the forward rate of Ca2+ binding to Syt I. Overall, our results shed new light on key molecular properties of CpxII that hinder premature exocytosis and accelerate synchronous exocytosis.